DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review (CDR) Tocilizumab (Actemra): Giant cell arteritis (GCA) Tenofovir alafenamide (Vemlidy): Hepatitis B, chronic CDR Update 135: Application Fees for CADTH Pharmaceutical Reviews — Adjustment CADTH pan-Canadian Oncology Drug Review (pCODR) Pembrolizumab (Keytruda): Metastatic Urothelial Ca...
DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review Nitisinone (Orfadin): Hereditary tyrosinemia type 1 Guselkumab (Tremfya): Psoriasis, moderate-to-severe plaque Infliximab (Renflexis): rheumatoid arthritis, ankylosing spondylitis, adult Crohn’s disease, pediatric Crohn’s disease, fistulising Crohn’s disease, adult ulcerative colitis, p...
DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review Migalastat (Galafold): Fabry Disease Cysteamine bitartrate (Procysbi): Nephropathic cystinosis Glecaprevir pibrentasvir (Maviret): Chronic Hepatitis C Apomorphine hydrochloride (Movapo): Parkinson's disease Sofosbuvir velpatasvir voxilaprevir (Vosevi): Chronic Hepatitis C CADTH pan-Cana...
DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review Read the following CDR Update to find out what’s happening in CDR: Issue 132 — Update on Revised Process for Biosimilars, and Clarification Regarding Eligibility Assessments for Resubmissions. Nusinersen (Spinraza): Spinal Muscular Atrophy CADTH pan-Canadian Oncology Drug Review (pCODR)...
DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review Read the following CDR Update to find out what’s happening in CDR: Issue 130 — Revised Procedure for the CADTH Common Drug Review Resubmissions, Industry Fees are Applicable to all CDR Resubmissions, and Revised Table of Studies Template. Issue 131 — Collaborative Workspaces: Revised Pr...
NEWS & EVENTS
Evidence-to-Action Series
We are pleased to present, as part of our Evidence-to-Action Series, Home-Based Dialysis in Canada: From Evidence to Practice, on Thursday, November 9, 2017, from 2:00 p.m. to 3:30 p.m. EST, in Ottawa. We are delighted to host Renal Patient Advocate Kirk Kelly, who will provide a patient perspect...
NEWS & EVENTS
CADTH Lecture Series
On October 12, 2017, Dr. Hakique Virani will be speaking about “Canada’s Opioid Crisis: The Changing Reality Between Exam Rooms and Ivory Towers.” Dr. Virani is currently the Medical Director of Metro City Medical Clinic, and Assistant Clinical Professor in the Department of Medicine at the University...
DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review Eliglustat (Cerdelga): Gaucher disease AbobotulinumtoxinA (Dysport Therapeutic): Cervical dystonia Etanercept (Erelzi): Ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, rheumatoid arthritis Glatiramer acetate (Glatect): Multiple sclerosis, relapsing-remitting ...
DRUG REIMBURSEMENT RECOMMENDATIONS
CADTH Common Drug Review
Daclizumab beta (Zinbryta): Multiple sclerosis, relapsing
CADTH pan-Canadian Oncology Drug Review (pCODR)
Axitinib (Inlyta) Request for Advice: Metastatic renal cell carcinoma
Obinutuzumab (Gazyva): Follicular lymphoma
Cancer Drug Pipeline Information
Launched in 2015, the Cancer ...
DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review Edoxaban (Lixiana VTE): Venous thromboembolism, treatment and recurrence prevention Emtricitabine/rilpivirine/tenofovir alafenamide (Odefsey): HIV-1 infection Ivabradine (Lancora): Heart failure, NYHA Class II or III CADTH pan-Canadian Oncology Drug Review (pCODR) Alectinib (Alecen...